These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2501273)

  • 61. In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients.
    Rolston K; Ho DH; LeBlanc B; Bodey GP
    Chemotherapy; 1988; 34(6):448-54. PubMed ID: 3149568
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin.
    Pohlod DJ; Saravolatz LD; Somerville MM
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():49-54. PubMed ID: 3144549
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vitro and in vivo activity of antifungal agents in combination with fleroxacin, a new quinolone.
    Polak A
    Mycoses; 1990 Apr; 33(4):173-8. PubMed ID: 2122247
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Penetration of ciprofloxacin and its desethylenemetabolite into skin in humans after a single oral dose of the parent drug assessed by cutaneous microdialysis.
    Bielecka-Grzela S; Klimowicz A
    J Clin Pharm Ther; 2005 Aug; 30(4):383-90. PubMed ID: 15985052
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effect of fleroxacin on hepatic drug metabolism in the rat.
    Grech-Bélanger O; Francoeur J; Le Bel M
    Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):121-33. PubMed ID: 2501838
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro studies of fleroxacin (Ro 23-6240), a new trifluorinated quinolone derivative.
    Digranes A; Benonisen E; Salveson A; Zahm F
    Chemotherapy; 1988; 34(5):401-10. PubMed ID: 3141116
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparative activities of norfloxacin and fleroxacin in experimental infections due to Salmonella typhimurium and Escherichia coli.
    Hof H; Fabrig J
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():123-7. PubMed ID: 3144530
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Penetration of ciprofloxacin into gynecologic tissues.
    Dalhoff A; Weuta H
    Am J Med; 1987 Apr; 82(4A):133-8. PubMed ID: 3555027
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In-vitro susceptibility of staphylococci to fleroxacin in comparison with six other quinolones.
    Pohlod DJ; Saravolatz LD; Somerville MM
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():35-41. PubMed ID: 3144547
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Penetration of cefotetan into serum, myometrium, endometrium and salpinges.
    Just HM; Petersen EE; Bassler M; Frank U; Daschner FD
    Chemotherapy; 1984; 30(5):305-7. PubMed ID: 6593163
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fleroxacin: in-vitro activity worldwide against 20,807 clinical isolates and comparison to ciprofloxacin and norfloxacin.
    Paganoni R; Herzog C; Braunsteiner A; Hohl P
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():3-17. PubMed ID: 3144545
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Distribution and binding kinetics of ciprofloxacin and ofloxacin in the hindlimb of the rat.
    Sanchez-Navarro A; Casquero-Dorado AC; Weiss M
    Pharm Res; 1999 Apr; 16(4):587-91. PubMed ID: 10227717
    [No Abstract]   [Full Text] [Related]  

  • 73. Pelvic tissue levels of cefuroxime.
    Pritchard JM; Elder MG; Kennedy MR
    J Infect; 1981 Jun; 3(2):193-4. PubMed ID: 7185961
    [No Abstract]   [Full Text] [Related]  

  • 74. Interactions of the oxygen-dependent antimicrobial system of the human neutrophil with difloxacin, ciprofloxacin, pefloxacin and fleroxacin in the intraphagocytic eradication of Staphylococcus aureus.
    van Rensburg CE; Joone G; Anderson R
    J Med Microbiol; 1990 May; 32(1):15-7. PubMed ID: 2111406
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Erythromycin and 2'-acetyl erythromycin concentrations in plasma and pelvic tissues after repeated doses of erythromycin acistrate.
    Lehtonen L; Wikberg R; Karhunen M; Kokkonen P; Tuominen R
    Arzneimittelforschung; 1993 Jan; 43(1):53-6. PubMed ID: 8447849
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Determination of ofloxacin in human fallopian tube, uterus and serum by high performance liquid chromatography].
    Zhu GD; Wei J; Liang WW; Xie MQ
    Yao Xue Xue Bao; 2002 Feb; 37(2):134-7. PubMed ID: 12579960
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The penetration of fleroxacin into bronchial mucosa.
    Wise R; Honeybourne D; Andrews JM; Ashby JP
    J Antimicrob Chemother; 1988 Aug; 22(2):203-6. PubMed ID: 3141344
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus).
    Kim MS; Lim JH; Park BK; Hwang YH; Yun HI
    J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Correlation between growth curves and killing curves of Escherichia coli in the presence of fleroxacin and ampicillin.
    Yourassowsky E; Van der Linden MP; Crokaert F
    Chemotherapy; 1989; 35(6):423-30. PubMed ID: 2515040
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues.
    Bacracheva N; Scholl H; Gerova Z; Chervenakov P; Dobrev P; Vlahov V
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):352-6. PubMed ID: 1937996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.